OR WAIT null SECS
August 12, 2019
The new facility will manufacture biopharmaceutical products under cGMP conditions.
August 08, 2019
South Korea’s pharma/biotech space is projected to grow to $23.2 billion by 2022, and will likely attract foreign investment, according to a new market report by GlobalData.
August 06, 2019
Under an agreement, Colorcon will incorporate TruTag’s edible microtag technology in its coatings.
August 02, 2019
A design strategy can ensure conflicting properties are managed appropriately for multi-API controlled-release formulations.
As vaccines gain prominence within pharma, there is an expectation that specialized CDMO services will provide opportunities.
To help customers succeed, CDMOs have moved away from the ‘fee-for-service’ model to offer flexible, full-service partnerships.
Complex and potent molecules demand greater technical and regulatory expertise to ensure safe handling.
Glass vials have come a long way from mere commodities and are now considered an integral part of final drug product.
Protein characterization is a critical part of drug development, but as there are still limitations with available techniques, industry needs to look at technological advances to meet the specific requirements of complex molecule characterization.
Formulators of parenteral drugs must be cautious of specific considerations and challenges that arise during development and manufacture.
